Featured & Latest News
Artrya strategically partnered with digital product companies Hatchd and Adapptor to implement our Artrya Salix product vision.
As AI and deep learning evolve, software can sometimes match human specialists in its accuracy for sensing, imaging, triaging or risk profiling tasks. Find out more about AI accuracy.
In two-and-a-half years, Artrya has developed a novel approach to the detection and reporting of coronary artery disease. We have grown into a $100m company with leading technology that can rewrite the medical history books.
Today is a momentous occasion in the life of a business that we created two and a half years ago.
Cardiac imaging is a specialised area of radiology practice to visualise the heart and its associated valves, vessels and other structures.
This week, Artrya announced a commercialisation agreement with Eversana to expand business into the UK.
The case for vulnerable plaque. Every 40 seconds across the United States, another person experiences a heart attack. According to the Centers for Disease Control and Prevention, myocardial infarctions (heart attacks)…
How Australian AI innovators are disrupting healthcare.
How digital transformation is changing disease diagnoses, monitoring and treatments.